This supposition is supported by our finding that the daily rate of CLL-cell division, which correlates with the extent of AID expression, correlates with poor prognostic markers (unmutated IgHV, levels of ZAP70 and CD38) (143, 192) and predicts time-to-first treatment (192). The gene discussed is CD38; the disease is B-cell chronic lymphocytic leukemia.